{"id":3674,"date":"2014-05-06T19:52:35","date_gmt":"2014-05-06T19:52:35","guid":{"rendered":"https:\/\/fundamentalis.com\/?p=3674"},"modified":"2014-05-06T19:52:35","modified_gmt":"2014-05-06T19:52:35","slug":"5-6-14-healthcare-earnings-deep-dive","status":"publish","type":"post","link":"https:\/\/fundamentalis.com\/?p=3674","title":{"rendered":"5.6.14: Healthcare Earnings Deep-Dive"},"content":{"rendered":"<p>Last weekend, in our Weekly Earnings Update <a href=\"https:\/\/fundamentalis.com\/?p=3654\">here<\/a>, we noted the strength in SP 500 earnings was coming from Technology and Healthcare.<\/p>\n<p>Thanks to Gregg Harrison of Thomson Reuters, T\/R provided us with some color on the HealthCare sector.<\/p>\n<p>Here is the spreadsheet <a href=\"https:\/\/fundamentalis.com\/wp-content\/uploads\/2014\/05\/FCHlthcare5514.xls\">FCHlthcare5514<\/a>\u00a0detailing the jump in HealthCare earnings over the last 5 weeks.<\/p>\n<p>According to Gregg Harrison, most of the increase is due to Gilead, the biotech giant that was on fire last year.<\/p>\n<p>According to our charts, Gilead was up over 100% for calendar 2014.<\/p>\n<p>Looking at the fundamentals, when GILD reported earnings on April 22nd, the expectation was for $0.91 in EPS and $3.99 billion in revenues. Actual results were $1.48 and $4.99 billion in revenues for actual upside surprises of 64% and 25% respectively.<\/p>\n<p>The stock is still trading below its March 25th high of $84.88 too.<\/p>\n<p>Q1 &#8217;14 SP 500 earnings are coming in stronger-than-expected, Our expectation was 3% &#8211; 5%, but I&#8217;m guessing that the 5% ceiling will be exceeded by mid-June &#8217;14.<\/p>\n<p>Growth stocks have been hit hard this year: Small-cap&#8217;s, Consumer Discretionary, Biotech, etc., but looking at\u00a0 a lot of our names that have reported (like\u00a0a Facebook), the growth is still there. (Long FB)<\/p>\n<p>Thanks for reading,<\/p>\n<p>Trinity Asset Management, Inc. by:<\/p>\n<p>Brian Gilmartin, CFA<\/p>\n<p>Portfolio manager<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Last weekend, in our Weekly Earnings Update here, we noted the strength in SP 500 earnings was coming from Technology&hellip;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[112,57,111],"tags":[],"class_list":["post-3674","post","type-post","status-publish","format-standard","hentry","category-biotech-sector-earnings","category-facebook-fb","category-gilead"],"jetpack_featured_media_url":"","jetpack_sharing_enabled":true,"post_mailing_queue_ids":[],"_links":{"self":[{"href":"https:\/\/fundamentalis.com\/index.php?rest_route=\/wp\/v2\/posts\/3674","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/fundamentalis.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/fundamentalis.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/fundamentalis.com\/index.php?rest_route=\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/fundamentalis.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3674"}],"version-history":[{"count":2,"href":"https:\/\/fundamentalis.com\/index.php?rest_route=\/wp\/v2\/posts\/3674\/revisions"}],"predecessor-version":[{"id":3677,"href":"https:\/\/fundamentalis.com\/index.php?rest_route=\/wp\/v2\/posts\/3674\/revisions\/3677"}],"wp:attachment":[{"href":"https:\/\/fundamentalis.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3674"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/fundamentalis.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3674"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/fundamentalis.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3674"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}